Effects of Ubiquitin-Proteasome Inhibitor MG-132 on Bleomycin Induced Pulmonary Fibrosis in Rats

叶燕青,张细曼
DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2013.03.022
2013-01-01
Abstract:OBJECTIVE To investigate the effects of ubiquitin-proteasome inhibitor MG-132 on pulmonary fibrosis in rats.METHODS 45 male SD rats were randomly divided into four groups: control group,model group,intervention group and treatment group.The model group,intervention group and treatment group were intratracheally instilled with bleomycin(5 mg·kg-1),the control group were subjected to equivalent saline.The intervention group were intraperitoneally injected with MG-132(0.1 mg·kg-1·d-1) from the first day after intratracheal instillation,the model group and control group were intraperitoneally injected with equivalent saline.The treatment group were intraperitoneally injected with MG-132(0.1 mg·kg-1·d-1) from 28th day after intratracheal instillation.The lung coefficient,lung pathological manifestations and level of hydroxyproline(HYP) in lung tissue were evaluated at different time points in each group.RESULTS The lung coefficient and level of HYP and in intervention group and treatment group were all lower than those of model group significantly(P0.01,P0.05),also the same of degree of alveolitis;although the degree of lung fibrosis in intervention group and model group and treatment group were all more severe than those of control group,whereas the degree of lung fibrosis in intervention group at 28th day and treatment group were lessened compared with those of model group.CONCLUSION Ubiquitin-proteasome inhibitor MG-132 can prevent and reduce pulmonary fibrosis to some degree in rats.
What problem does this paper attempt to address?